FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377521001: Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3680143014 Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3680145019 Levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4727251000005117 levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a Product containing liothyronine (medicinal product) false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hormone false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Thyroid hormone false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a levothyroxinnatriumpræparat false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levothyroxine sodium false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a levothyroxinnatrium + liothyroninnatrium false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Liothyronine false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Liothyronine sodium false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a Liothyronine-containing product in oral dose form false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a Product containing levothyroxine sodium in oral dosage form false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has presentation strength denominator value en false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has presentation strength denominator value en false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Liothyronine sodium false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Liothyronine sodium false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has presentation strength numerator value 9 false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levothyroxine sodium false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Levothyroxine sodium false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has presentation strength numerator value 38 false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a Levothyroxine- and liothyronine-containing product in oral dose form false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Levothyroxine sodium false Inferred relationship Some 2
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Liothyronine sodium false Inferred relationship Some 1
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Count of base of active ingredient to false Inferred relationship Some
    levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet Is a Levothyroxine and liothyronine only product in oral dose form false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start